
Sionna Therapeutics, Inc Common Stock
Quarterly Financials
| Values in thousands | 2026-09-30 | 2026-06-30 | 2026-03-31 | 2025-12-31 |
|---|---|---|---|---|
Revenue | $0 | $0 | $0 | $0 |
Gross Profit | -154 | -154 | -152 | |
EBITDA | -28,465 | -29,731 | -26,625 | -16,760 |
EBIT | -28,619 | -29,886 | -26,779 | -17,263 |
Net Income | -32,418 | -29,886 | -26,779 | -20,440 |
Net Change In Cash | 0 | 0 | 0 | 0 |
Free Cash Flow | -18,723 | -44,060 | -21,840 | -16,830 |
Cash | 83,878 | 63,322 | 63,324 | 58,451 |
Basic Shares | 45,208 | 45,148 | 44,921 | 39,962 |
Annual Financials
| Values in thousands | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
Revenue | $0 | $0 | $0 | $0 |
Gross Profit | -647 | -668 | ||
EBITDA | -74,621 | -61,020 | -46,680 | -40,118 |
EBIT | -75,268 | -61,688 | -47,263 | -40,240 |
Net Income | -75,268 | -61,688 | -47,263 | -40,240 |
Net Change In Cash | 0 | 0 | 0 | 0 |
Free Cash Flow | -66,674 | -52,814 | -44,815 | -37,942 |
Cash | 58,451 | 37,788 | 38,521 | 54,837 |
Basic Shares | 39,962 | 44,124 | 44,124 | 44,124 |
Earnings Calls
| Quarter | EPS |
|---|---|
2026-09-30 | -$0.72 |
2026-06-30 | -$0.66 |
2026-03-31 | -$0.60 |
2025-12-31 | -$0.46 |